Replimune Stock Rockets 100% on FDA Nod – Analysts Eye Upside
Stock Performance and Recent Rally Replimune’s stock has been extremely volatile in 2025. It soared on Oct. 20 after the FDA acceptance news: shares nearly doubled from about $4.50 to $8.94 that